Randomized phase II study of everolimus (E), leuprolide + letrozole (LL), and E + LL (ELL) in patients (pts) with unresectable fibrolamellar carcinoma (FLC) Meeting Abstract
| Authors: | Abou-Alfa, G. K.; Mayer, R. J.; Cosgrove, D.; Capanu, M.; Choti, M. A.; Atreya, C. E.; Ang, C.; Kelley, R. K.; Do, R. K. G.; Gordan, J. D.; Zhu, A. X.; Ly, M.; Nolan, P.; Lubin, L.; Harding, J. J.; Saltz, L.; Venook, A. P. |
| Abstract Title: | Randomized phase II study of everolimus (E), leuprolide + letrozole (LL), and E + LL (ELL) in patients (pts) with unresectable fibrolamellar carcinoma (FLC) |
| Meeting Title: | 51st Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 33 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2015 May 29-Jun 2 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2015-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358036902918 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2015.33.15_suppl.e15149 |
| Notes: | Meeting Abstract: e15149 -- Source: Wos |
